Pseudomonas aeruginosa-derived volatile organic compounds modulate host immunity to disrupt airway mucus homeostasis
Open Access
- 26 August 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1823251
Abstract
Chronic pulmonary diseases, including cystic fibrosis, chronic obstructive pulmonary disease, and chronic bronchitis, as well as ventilator-associated pneumonia, are characterized by persistent infection of mucus-laden airways. Pseudomonas aeruginosa (PA) is a dominant pathogen in these conditions and produces volatile organic compounds (VOCs) that have been proposed as biomarkers of disease exacerbation; however, their immunopathogenic roles remain unclear. We investigated PA-derived VOCs using human bronchial epithelial air–liquid interface cultures and murine models. VOCs exposure significantly increased airway mucin expression and induced a proinflammatory response characterized by M1 macrophage polarization (iNOS + ), neutrophil recruitment, and expansion of IL-17A–producing Thy1.2 + lymphocytes. Functional depletion of macrophages, neutrophils, or IL-17A in vivo each attenuated mucin production and goblet cell metaplasia, indicating non-redundant contributions to mucus pathology. In vitro , IL-17A neutralization partially restored FOXA2 expression and reduced mucin production, supporting a role in mucus regulation. On the mechanistic level, we discovered an IL-17A-dependent dual-axis pathway involving both epithelial cell-mediated autocrine and lymphocyte-mediated paracrine signaling that contributes to the feed-forward loop of inflammation and enhances the signaling pathways regulating mucus hypersecretion in airways. We conclude that PA VOCs activate multiple proinflammatory responses to convergently drive mucus pathogenesis in the diseased lung.Keywords
This publication has 91 references indexed in Scilit:
- Pseudomonas aeruginosa2022
- Pulmonary Mycosis Drives Forkhead Box Protein A2 Degradation and Mucus Hypersecretion through Activation of the Spleen Tyrosine Kinase–Epidermal Growth Factor Receptor–AKT/Extracellular Signal-Regulated Kinase 1/2 SignalingThe American Journal of Pathology, 2020
- Analysis of volatile metabolites from in vitro biofilms of Pseudomonas aeruginosa with thin-film microextraction by thermal desorption gas chromatography-mass spectrometryAnalytical and Bioanalytical Chemistry, 2020
- IL-17A-induced neutrophilic airway inflammation is mediated by oxidant-antioxidant imbalance and inflammatory cytokines in miceBiomedicine & Pharmacotherapy, 2018
- Diesel exhaust particles up-regulate interleukin-17A expression via ROS/NF-κB in airway epitheliumBiochemical Pharmacology, 2018
- Partners in crime: neutrophils and monocytes/macrophages in inflammation and diseaseCell and tissue research, 2018
- Immunity to infection in IL‐17‐deficient mice and humansEuropean Journal of Immunology, 2012
- Quantification of methyl thiocyanate in the headspace of Pseudomonas aeruginosa cultures and in the breath of cystic fibrosis patients by selected ion flow tube mass spectrometryRapid Communications in Mass Spectrometry, 2011
- Hydrogen cyanide as a biomarker for Pseudomonas aeruginosa in the breath of children with cystic fibrosisPediatric Pulmonology, 2009
- The analysis of 1‐propanol and 2‐propanol in humid air samples using selected ion flow tube mass spectrometryRapid Communications in Mass Spectrometry, 2005